Cortez, Cristine Jane D.
HRN: 28-26-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
METRONIDAZOLE 500MG (TAB)
12/16/2025
12/22/2025
PO
500mg
TID
THICKLY MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes